Aura Biosciences (AURA): CFO sold ~$302K
Julie B Feder, CFO at Aura Biosciences, sold ~$302K of Aura Biosciences shares.
- ~$302K
- Approx. value · 25K sh @ $12.03
- 134K
- Holds after · shares reported
- Traded
- Oct 18, 2024
- Filed
- Oct 21, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 16, 2024InsiderOfficer sold ~$73K of AURA shares in the open market
- Oct 18, 2024 · this disclosureInsiderCFO sold ~$302K of AURA shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Aura Biosciences
For Aura Biosciences, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AURA page.
How this filing works
Explore the data
Common questions
Which Aura Biosciences (AURA) insider traded, and how much?
Julie B Feder, CFO at Aura Biosciences, sold ~$302K of Aura Biosciences shares. 25K shares at $12.03.
When did it happen, and when was it made public?
Traded: Oct 18, 2024. Filed: Oct 21, 2024. That is 3 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Aura Biosciences recently?
For Aura Biosciences, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the AURA page.
Does this mean AURA stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Aura Biosciences
- SEC Schedule 13GNov 16, 2026
- SEC Form 144Nov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Schedule 13GNov 13, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its AURA page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
